Education
School — Major — Degree | Duration |
---|---|
國立成功大學 — 基礎醫學研究所(畢) — 博士 Doctorate, Institute of Basic Medical Science, National Cheng Kung University |
2005/09 — 2014/07 |
長庚大學 — 基礎醫學研究所(畢) — 碩士 Master, Graduate Institute of Basic Medical Science, Chang Gung University |
2000/09 — 2003/01 |
國立屏東科技大學 — 農園生產系(畢) — 學士 Bachelor, Department of Plant Industry, National Pingtung University of Science and Technology |
1995/09 — 1999/06 |
Intramural Experience
Office/Department/Institute | Position | Duration |
---|---|---|
解剖學科 Department of Anatomy | Assistant Professor | 2023/08/01 — |
解剖學科 Department of Anatomy | Assistant Professor | 2023/02/01 — 2023/07/31 |
Extramural Experience
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
Area(s) of Expertise & Research
Publication
NO | Publication |
---|---|
1 | Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer. Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer. |
2 | The role of Atg5 gene in tumorigenesis under autophagy deficiency conditions. The role of Atg5 gene in tumorigenesis under autophagy deficiency conditions. |
3 | Revealing potential Rab proteins participate in regulation of secretory autophagy machinery Revealing potential Rab proteins participate in regulation of secretory autophagy machinery |
4 | Evodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancers. Evodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancers. |
5 | Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells. Honokiol Suppresses Cell Proliferation and Tumor Migration through ROS in Human Anaplastic Thyroid Cancer Cells. |
Project
NO |
YEAR — Source — No — Type
Project Name
|
Duration |
---|---|---|
1 |
113 — Q 新聘教師計畫(校內) — KMU-Q114012 —
探討受體酪胺酸激酶在癌症幹細胞與抗藥性所扮演的角色( )
|
2025/01/01 ~ 2025/12/31 |